Literature DB >> 10469797

Off-label uses of drugs in children.

J L Blumer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10469797

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  25 in total

1.  Suspected adverse drug reactions reported for children worldwide: an exploratory study using VigiBase.

Authors:  Kristina Star; G Niklas Norén; Karin Nordin; I Ralph Edwards
Journal:  Drug Saf       Date:  2011-05-01       Impact factor: 5.606

Review 2.  The QT interval and psychotropic medications in children: recommendations for clinicians.

Authors:  Paul McNally; Fiona McNicholas; Paul Oslizlok
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-08-29       Impact factor: 4.785

3.  Package inserts and the standard of care.

Authors:  Russell G Thornton
Journal:  Proc (Bayl Univ Med Cent)       Date:  2003-10

4.  Where physicians look for information on drug prescribing for children.

Authors:  Doreen M Matsui; Mary Elizabeth Jardine; Erin Steer; Victoria Cukernik; Michael J Rieder
Journal:  Paediatr Child Health       Date:  2003-04       Impact factor: 2.253

5.  The physician's role and responsibility in reporting adverse drug events in children.

Authors:  Robert G Peterson; Chris Turner
Journal:  Paediatr Child Health       Date:  2003-04       Impact factor: 2.253

Review 6.  The need for and creation of a comprehensive pediatric research network.

Authors:  Esther Y Yoon; Gary L Freed
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022

7.  Use pattern and off-label use of atypical antipsychotics in bipolar disorder, 1998-2002.

Authors:  Jeffery A Demland; Yonghua Jing; Christina M L Kelton; Jeff J Guo; Hong Li; Patricia R Wigle
Journal:  Am Health Drug Benefits       Date:  2009-06

Review 8.  Issues in the formulation of drugs for oral use in children: role of excipients.

Authors:  Shiwaji Pawar; Ashir Kumar
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

9.  Geographic location of antiretroviral clinical trials in HIV infected pediatric patients.

Authors:  Katie J Suda; Jodie Greene; Chasity M Shelton
Journal:  Int J Clin Pharm       Date:  2013-09-19

10.  Documentation of pediatric drug safety in manufacturers' product monographs: a cross-sectional evaluation of the canadian compendium of pharmaceuticals and specialities.

Authors:  Navjeet K Uppal; Lee L Dupuis; Christopher S Parshuram
Journal:  Paediatr Drugs       Date:  2008       Impact factor: 3.022
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.